Previous close | 9.18 |
Open | 9.20 |
Bid | 8.59 x 800 |
Ask | 9.00 x 3200 |
Day's range | 8.76 - 9.24 |
52-week range | 7.12 - 14.59 |
Volume | |
Avg. volume | 670,867 |
Market cap | 442.363M |
Beta (5Y monthly) | N/A |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
DALLAS, May 23, 2024--Enhabit, Inc. (NYSE: EHAB) ("Enhabit" or the "Company") today announced that it has filed its preliminary proxy materials with the Securities and Exchange Commission (the "SEC") in connection with its upcoming 2024 annual meeting of stockholders (the "2024 Annual Meeting"). The preliminary proxy statement is available on the Investor Relations section of the Enhabit website at investors.ehab.com.
DALLAS, May 21, 2024--Enhabit, Inc. (NYSE: EHAB), a leading national home health and hospice provider, today announced its participation in the Goldman Sachs 45th Annual Global Healthcare Conference.
DALLAS, May 20, 2024--Enhabit, Inc. (NYSE: EHAB), a leading national home health and hospice provider, today announced its participation in the Leerink Partners Healthcare Crossroads Conference 2024.